Distinguishing Autoimmune Hepatitis From Steatohepatitis in Adolescents With Obesity and Positive Screening Alanine Aminotransferase
- PMID: 37200725
- PMCID: PMC10187841
- DOI: 10.1097/PG9.0000000000000292
Distinguishing Autoimmune Hepatitis From Steatohepatitis in Adolescents With Obesity and Positive Screening Alanine Aminotransferase
Abstract
Screening children with obesity for nonalcoholic fatty liver disease leads to identification of elevated alanine aminotransferase (ALT) and is a common cause for referral to pediatric gastroenterology. Guidelines recommend that children with positive screening ALT be evaluated for causes of ALT elevation beyond nonalcoholic fatty liver disease. One clinical challenge is that autoantibodies can be present in patients with obesity and thus may or may not represent autoimmune hepatitis. This case series highlights the importance of a comprehensive evaluation to reach an accurate diagnosis.
Keywords: liver histology; nonalcoholic fatty liver disease; ultrasound.
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.
Conflict of interest statement
The authors report no conflicts of interest.
Figures


Similar articles
-
The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.Am J Gastroenterol. 1999 Apr;94(4):1018-22. doi: 10.1111/j.1572-0241.1999.01006.x. Am J Gastroenterol. 1999. PMID: 10201476
-
Comparison between non-alcoholic fatty liver disease screening guidelines in children and adolescents.JHEP Rep. 2019 Jul 9;1(4):259-264. doi: 10.1016/j.jhepr.2019.06.005. eCollection 2019 Oct. JHEP Rep. 2019. PMID: 32039376 Free PMC article.
-
Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected non-alcoholic fatty liver disease.Aliment Pharmacol Ther. 2013 Nov;38(10):1267-77. doi: 10.1111/apt.12518. Epub 2013 Oct 1. Aliment Pharmacol Ther. 2013. PMID: 24117728 Free PMC article.
-
Emerging New Diagnostic Modalities and Therapies of Nonalcoholic Fatty Liver Disease.Curr Gastroenterol Rep. 2020 Aug 19;22(10):52. doi: 10.1007/s11894-020-00786-y. Curr Gastroenterol Rep. 2020. PMID: 32814993 Review.
-
[Management of asymptomatic elevated serum aminotransferase levels, particularly in nonalcoholic steatohepatitis].Ned Tijdschr Geneeskd. 1999 Mar 6;143(10):506-9. Ned Tijdschr Geneeskd. 1999. PMID: 10321258 Review. Dutch.
Cited by
-
Reply to letter to the editor in response to: Distinguishing autoimmune hepatitis from steatohepatitis in adolescents with obesity and positive screening alanine aminotransferase.JPGN Rep. 2024 Feb 12;5(2):240-241. doi: 10.1002/jpr3.12049. eCollection 2024 May. JPGN Rep. 2024. PMID: 38756115 Free PMC article. No abstract available.
-
Letter to the editor in response to distinguishing autoimmune hepatitis from steatohepatitis in adolescents with obesity and positive screening alanine aminotransferase.JPGN Rep. 2024 Feb 28;5(2):238-239. doi: 10.1002/jpr3.12050. eCollection 2024 May. JPGN Rep. 2024. PMID: 38756137 Free PMC article. No abstract available.
References
-
- Schwimmer JB, Deutsch R, Kahen T, et al. . Prevalence of fatty liver in children and adolescents. Pediatrics. 2006;118:1388–1393. - PubMed
-
- Deneau M, Jensen MK, Holmen J, et al. . Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history. Hepatology. 2013;58:1392–1400. - PubMed
-
- Radhakrishnan KR, Alkhouri N, Worley S, et al. . Autoimmune hepatitis in children—impact of cirrhosis at presentation on natural history and long-term outcome. Dig Liver Dis. 2010;42:724–728. - PubMed
-
- Vos MB, Abrams SH, Barlow S, et al. . NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the expert committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr. 2017;64:319–334. - PMC - PubMed
-
- Khayat A, Vitola B. Prevalence and clinical significance of autoantibodies in children with overweight and obesity with nonalcoholic fatty liver disease. J Pediatr. 2021;239:155–160. - PubMed
Publication types
LinkOut - more resources
Full Text Sources